Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2023; 69(3): 31-38


V.M. Ganyuk1, O.V. Petrenko1, L.V. Natrus2

  1. Shupyk National University of Health Care of Ukraine, Kyiv, Ukraine
  2. Bogomolets National Medical University, Kyiv, Ukraine


The supply of glucose to neurons of the brain and retina is carried out by a specific, facilitated transport with the participation of sodium-independent glucose transporters of the GLUT family. Studying the mechanisms of glucose transport with pharmacological or genetic inhibition of transporters is considered as a promising way to reduce glucose-toxic damage to the retina to prevent diabetic retinopathy. We studied the content of GLUT1, GLUT3, GLUT4 and Hypoxia inducible factor 1 alpha (HIF-1α) in the plasma of patients with different stages of proliferative diabetic retinopathy (PDR), duration of type 2 diabetes (T2D) was up to 20 and over 20 years, and control group. Research on the level of transporters in the blood plasma was carried out by the method of immuno-enzymatic analysis using Elabscience kits (USA). No significant difference in the GLUT1 and GLUT4 blood plasma content was found between patients with PDR and control individuals, and the GLUT3 content was 2-fold higher. Also, the content of HIF-1α was 25% higher. No significant fluctuations in the content of transporters GLUT1, GLUT3, GLUT4, HIF-1α were found depending on the duration of T2DM, the degree of deepening of PDR and the level of hyperglycemia. Correlation analysis revealed a significant two-way correlation of the GLUT3 index with blood glucose level (r = 0.581), HbA1C (r = 0.553), GLUT1 (r = 0.440) and GLUT4 (r = 0.372). The conservatism of GLUT1 transporter content in the studied groups gives a reason to consider protein expression as genetically determined for the basic maintenance of homeostasis. The GLUT3 content increase in patients with PDR, which does not depend on the retinal damage degree, duration of T2D and glucose concentration, defines this mechanism of transport as the main pathogenetic link of glucose toxicity in neurons against the background of chronic hyperglycemia. Insulin-dependent transporter GLUT4 is probably not involved in the occurrence of PDR under of T2D.

Keywords: glucose transporters; GLUT1; GLUT3; GLUT4; HIF-1α; hyperglycemia; disbalance of carbohydrate metabolism; proliferative diabetic retinopathy.


  1. Le HG, Shakoor A. Diabetic and retinal vascular eye disease. Med Clin North Am. 2021;105(3):455-72. CrossRef PubMed
  2. Kumagai AK, Glasgow BJ, Pardridge WM. GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. Invest Ophthalmol Vis Sci. 1994;35:2887-94.
  3. Shima T, Taniguchi K, Tokumaru Y, Inomata Y, Arima J, Lee SW, Takabe K, Yoshida K, Uchiyama K. Glucose transporter-1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells. Oncol Rep. 2022;47(1):7. CrossRef PubMed PubMedCentral
  4. Chen H, Zhang X, Liao N, Ji Y, Mi L, Gan Y, Su Y, Wen F. Decreased expression of Glucagon-like peptide-1 receptor and Sodium-glucose co-transporter 2 in patients with proliferative diabetic retinopathy. Front Endocrinol (Lausanne). 2022;17;13: 1020252. CrossRef PubMed PubMedCentral
  5. Pardridge WM, Boado RJ. Molecular cloning and regulation of gene expression of blood-brain barrier glucose transporter. In: The Blood-brain Barrier. Cellular and Molecular Biology, 1993; pp. 395-440. Raven Press, New York.
  6. Leão LL, Tangen G, Barca ML, et al., Does hyperglycemia downregulate glucose transporters in the brain? Med Hypothes. 2020;139:109614. CrossRef PubMed
  7. Bhatti JS, Sehrawat A, Mishra J, et al. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. Free Rad Biol Med. 2022;184:114-34. CrossRef PubMed
  8. Li HY, Yuan Y, Fu YH, Wang Y, Gao XY. Hypoxiainducible factor-1α: A promising therapeutic target for vasculopathy in diabetic retinopathy. Pharmacol Res. 2020;159:104924. CrossRef PubMed
  9. Zhang D, Lv FL, Wang GH. Effects of HIF-1α on diabetic retinopathy angiogenesis and VEGF expression. Eur Rev Med Pharmacol Sci. 2018;22(16):5071-6.
  10. Davis M, Fisher M, Gangnon R, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early treatment diabetic retinopathy study report 18. Invest Ophthalmol Vis Sci. 1998;39: 233-52.
  11. Dakic T, Jevdjovic T, Lakic I, et al. Food for thought: shortterm fasting upregulates glucose transporters in neurons and endothelial cells, but not in astrocytes. Neuroche Res. 2019;44:388-99. CrossRef PubMed
  12. Knott RM, Robertson M, Muckersie E, Forrester JV. Regulation of glucose transporters (GLUT-1 and GLUT-3) in human retinal endothelial cells. Biochem J. 1996;15;318:313-7. CrossRef PubMed PubMedCentral
  13. Holoman NC, Aiello JJ, Trobenter TD, et al. Reduction of Glut1 in the neural retina but not the RPE alleviates polyol accumulation and normalizes early characteristics of diabetic retinopathy. J Neurosci. 2021;7;41(14):3275-99. CrossRef PubMed PubMedCentral
  14. Wu Y, Zou H. Research progress on mitochondrial dysМатеріал надійшов до редакції 14.02.2023 function in diabetic retinopathy. Antioxidants (Basel). 2022;15;11(11):2250. CrossRef PubMed PubMedCentral
  15. Ashrafi G, Wu Z, Farrell RJ, Ryan TA. GLUT4 mobilization supports energetic demands of active synapses. Neuron. 2017;93:606-15. CrossRef PubMed PubMedCentral

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.